Dewpoint Therapeutics
Biotechnology ResearchView the employees at
Dewpoint Therapeutics-
Erik Martin Associate Principle Scientist at Dewpoint Therapeutics
-
Boston, Massachusetts, United States
-
Rising Star
John Manteiga Senior Scientist at Dewpoint Therapeutics-
Boston, Massachusetts, United States
-
Top 10%
Kamran Rizzolo, Ph.D. Senior Scientist at Dewpoint Therapeutics-
Greater Boston
-
Rising Star
Marty Fernandez Senior Scientist at Dewpoint Therapeutics-
Melrose, Massachusetts, United States
-
Top 10%
Overview
Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.
-